Adagio Medical Holdings (ADGM) Price to Sales (2024)
Adagio Medical Holdings' (ADGM) quarterly Price to Sales came in at 284.1 in Q3 2024.
Powered by 
Analysis
Adagio Medical Holdings (ADGM) Price to Sales (2024) Analysis & Trends
Adagio Medical Holdings has disclosed Price to Sales across 1 years of filings, most recently posting 284.1 for Q3 2024.
- In Q3 2024, Price to Sales changed N/A year-over-year to 284.1; the TTM figure through Sep 2025 stood at 226.06 (up 195.38% YoY), while the FY2024 annual figure was 59.32, changed N/A from the prior year.
- Price to Sales came in at 284.1 for Q3 2024 at Adagio Medical Holdings.
- In the past five years, Price to Sales ranged from a high of 284.1 in Q3 2024 to a low of 284.1 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Adagio Medical Holdings | 13.45 Mn | 13.45 Mn | - |